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The present investigation aims to isolate, characterise and evaluate the phytoconstituents of Gomphrena serrata L. 
responsible for hepatoprotective activity in carbon tetrachloride-induced hepatotoxicity models both in vitro and in vivo. The 
plant species has not been explored for various therapeutic activities. HPLC analysis of subfraction of plant extract showed 
the presence of piperine, which was isolated and further hydrolysed to piperic acid. The results of the study indicate that the 
plant hydroalcoholic, acetone extracts at 500 mg/kg and compound piperic acid at 0.5 mg/kg exhibited better results in the 
regeneration of damaged hepatocytes and reduction of biochemical marker enzymes. The hepatoprotective activity might  
be due to inhibition of cytochrome P450 2E induced ER and oxidative stress. The present study reveals that the 
hepatoprotective activity of floral extracts might be due to in situ conversion of piperine into piperic acid. As piperic acid 
showed the equipotent potential to standard drug silymarin, it can be further developed as a hepatoprotective drug.  
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Introduction 
The plant kingdom is an enormous resource of 
therapeutic entities. Therapeutic search for novel 
molecules always drives researchers to herbs. Damage 
to liver and liver diseases has become a common 
problem worldwide1. Alcohol abuse and nonalcoholic 
fatty liver disease (NAFLD), a metabolic disorder, 
which promote oxidative stress and inflammation, are 
the most common causes of hepatic damage2. Cirrhosis, 
jaundice and fatty liver include the more prominent liver 
diseases3. Current pharmacotherapy of liver disorders 
uses a limited number of drugs with profound side 
effects. Herbal medicines are used in the treatment of 
hepatic problems4. The therapeutic area of hepatic 
problems requires novel hepatoprotective agents with 
different modes of action. The drugs which activate 
endoplasmic reticulum (ER) stress response evolve as 
better therapeutic agents for hepatic problems5. 
The genus Gomphrena is cosmopolitan with 140 
species occurring in different temperate, and 
subtropical regions of the world. Many plants of the 
family Amaranthaceae are employed in folk medicine 
for their nutritive assets and treatment of several 
diseases. The plant G. serrata L. Amaranthaceae is an 
ornamental, edible, roadside plant grown in the 
regions of America, Antarctica, and Indo-Malaysia. 
The plant species has not been explored scientifically 
much for phytochemical and pharmacological studies. 
The closest species G. celoisoides is often confused 
with G. serrata6 and hence selected plant species  
(G. serrata) has been neglected. The genus 
Gomphrena is being used for the treatment of 
jaundice, high cholesterol and urinary problems in 
Latin America and Caribbean7,8. The folklore people 
of different regions use G. Serrata leaf extracts as 
natural blood coagulators, and the whole plant 
extracts in cardiovascular and diabetic disorders9-11. 
The whole plant alcoholic, aqueous and n-hexane 
extracts were studied for antibacterial properties 
against Bacillus cereus and Escherichia coli12. 
Oleuropein was isolated from the plant extracts13. The 
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plant acetone and hydroalcoholic floral extracts have 
been found to exhibit antiasthmatic activity by 
antihistaminic and anticholinergic models14. The 
chloroform fraction of acetone floral extract of the 
plant species was subjected to gas chromatography-
mass spectrometry (GC-MS) analysis15. In order to 
explore the therapeutic principles of G. serrata, an 
attempt has been made to isolate, characterize, and 
evaluate its hepatoprotective potential.  
 
Materials and Methods 
 
Plant material 
The plant material (Fig. 1,2) was collected from 
local grounds of Prasadampadu and Enikepadu 
coordinates 16°32′45″N 80°34′12″E of Vijayawada 
rural region, Krishna district, Andhra Pradesh, India. 
Dr. P. Satya Narayana Raju, Plant Taxonomist, 
Department of Botany & Microbiology, Acharya 
Nagarjuna University, Guntur, Andhra Pradesh, India, 
identified and authenticated the plant specimen. A 
voucher specimen (001/VIPW) was deposited in the 
Department of Pharmacognosy, Vijaya Institute of 
Pharmaceutical Sciences for Women, Enikepadu, 
Vijayawada, for future reference.  
 
General chemicals 
Azocarmine, aniline blue, carnoy, and silymarin 
were purchased from Sigma-Aldrich Chemical Co., 
biochemical kits were purchased from Span Diagnostic 
Limited, Surat, India. All other chemicals used were of 
analytical grade and commercially available. 
 
Animals 
Wistar rats (100–150 g) of either sex were purchased 
from Mahaveer enterprises, Hyderabad, Telangana, 
India, housed in standard conditions of temperature 
(22±2 oC), relative humidity (55±5 %), and light (12 h 
light/dark cycles). They were fed with standard pellet 
diet and water ad libitum. The experimental protocol 
was approved (No 012/IAEC/NCPA/PhD/2016-17) by 
the Institutional Animal Ethical Committee of Nirmala 
College of Pharmacy, Atmakur, Mangalagiri, Guntur 
district, Andhra Pradesh, India, nominated by 
Committee for the Purpose of Control and Supervision 
of Experiments on Animals (CPCSEA), Department of 
Animal husbandry, Ministry of Environment and 
Forests, Government of India.  
 
Isolation of phytoconstituents 
Various methods of extraction are used for 
isolation of different alkaloids from plant material. In 
the extraction and isolation of alkaloids, one has to 
consider that alkaloids usually occur in plants as salts 
of organic or inorganic acids. The procedure of 
extraction depends on the class of alkaloids present16. 
The study has been planned to isolate alkaloids. Plant 
material (1 kg) was initially extracted with light 
petroleum ether two times (2 L×2) to remove fatty 
materials, moistened with the dilute ammonia solution 
(1 L) and extracted with chloroform (2 L) by Soxhlet 
apparatus for 24 hours. The obtained extract was dried 
using a rotary vacuum evaporator. The dried 
chloroform extract (12.0 g) was subjected to column 
chromatography (Silica gel 60 for the column, 60-120 
mesh, Merck, India) in chloroform. The chloroform 
fractions (F1-F5), 25 mL each was collected at a flow 
rate of 4-5 mL for every 2 minutes. The collected 
fractions were subjected to TLC studies with various 
solvent systems (Table 1,2) to separate different 
groups of alkaloids present. The pH of fractions was 
 
 
Fig. 1 — Gomphrena serrata plant 
 
 
 
Fig. 2 — Flowering twigs of Gomphrena serrata 
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adjusted with 25% ammonia17-19. All the TLC plates 
were treated with Dragendorff’s reagent and iodine 
vapour separately for the development of spots. Rf 
values were calculated for the well-developed 
chromatograms and compared with corresponding 
literature reports. The fractions (F1-F5) were 
subjected to column chromatography and run using 
TLC solvent systems (Table 2) to collect subfractions 
(Fa-Fe). The subfractions (Fa-Fe) were subjected to 
TLC with appropriate solvent systems20,21 (Table 2). 
The subfraction Fc that showed yellow spot was 
studied by HPLC analysis22,23 using standard drug 
piperine. Further, the phytochemical piperine 
belonging to a pyridine-piperidine group was isolated 
and hydrolysed to piperic acid.  
 
Instrument and chromatographic conditions for HPLC analysis 
of piperine 
HPLC analysis was performed on the Shimadzu LC-
20 system (Shimadzu, Kyoto, Japan) equipped with a 
pump (LC-20AD), autosampler (SIL-20A), and column 
oven and diode array detector (SPD-M20A). The output 
signal of the detector was recorded using LC Solution 
software at 343 nm. The separation was executed on a 
YMC-Pack ODS-A C18 (250 mm×4.6 mm, 5 μm). 
 
Preparation of mobile phase for quantification of piperine 
The mobile phase composed of acetonitrile:water: 
acetic acid (60:39.5:0.5 v/v) at a flow rate of  
1.0 mL/min. The injection volume was 20 µL (Table 1; 
Fig. 3,4).  
 
Preparation of standard solution for quantification of piperine 
The standard stock solution was prepared by taking 
5 mg of piperine, dissolved in 1 mL of the mobile 
phase. The standard working solution was prepared 
by taking 0.2 mL of standard stock solution and made 
up to 1 mL by mobile phase to get 1000 μg/mL. The 
sample was sonicated for 10 min and filtered before 
injection and quantified (Table 1; Fig. 3,4). 
 
Table 2 — TLC profile of column fractions 
S. No Type of alkaloid pH TLC Mobile phase 
Fr. F1-F5 
TLC Mobile phase 
Sub Fr. Fa-Fe 
1. Phenanthrene 9.0 F1 
Benzene:ethanol (17:1) 
Fa 
Ethylacetate:methanol:water (8:1:1) 
2. Quinoline 10.5 F2 
Chloroform:methanol (85:15) 
Fb 
Methanol:n-hexane (7:3) 
3. Pyridazine 10.0 F3 
Dichloromethane:methanol (83:17) 
Fc 
Toluene:ethylacetate (7:3) 
4. Indole 8.5 F4  
Chloroform:ethanol (9:1) 
Fd 
Methanol:chloroform (8:2) 
5. Pyrrolizdine 8 F5 
Toluene:ethylacetate:diethylamine (70:20:1) 
Fe 
Hexane:ethylacetate (1:1) 
 
 
Table 1 — Quantification of piperine in the standard and test 
samples by HPLC 
Sample Concentration 
(mg/mL) 
Rt (min) Area %  
Standard Piperine 1 5.67 916100 98 
Test sub fraction Fc 1 5.61 37085 3.92 
 
 
 
Fig. 3 — HPLC chromatogram of standard piperine 
 
 
 
Fig. 4 — HPLC chromatogram of piperine from test subfraction Fc 
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Preparation of sample solution for quantification of piperine 
The test sample stock solution was prepared using 
5 mg of the dried sample of subfraction Fc dissolved 
in 1 mL of the mobile phase. The test working 
solution was prepared by taking 0.2 mL of test stock 
solution and made up to 1 mL by mobile phase to get 
1000 μg/mL. The sample was sonicated for 10 min, 
filtered before injection, and quantified22,23 (Table 1; 
Fig. 3,4). 
 
Isolation of piperine 
The powder of the plant material was refluxed with 
95% ethanol for six hours. The solution was 
concentrated to required volume using a rotary 
evaporator and warm ethanolic potassium hydroxide 
was added to it. It was shaken well and filtered. The 
filtrate was added with cold water to develop 
turbidity. It was kept overnight for the formation of 
the yellow precipitate of piperine. Further, it was 
recrystallised using hot acetone-hexane at 3:2 ratios 
and kept on ice to promote the formation of yellow 
needle-like crystals of piperine24. The obtained 
product (70.1 mg) was analyzed by various physico-
chemical studies such as appearance, solubility, 
melting point, Rf value, specific chemical test and 
compared with literature data (Fig. 5a). 
 
Hydrolysis/degradation of piperine to piperic acid 
The obtained piperine (70.1 mg) was collected.  
It is a very weak base, which upon hydrolysis  
with acid or base decomposes into volatile base 
piperidine and piperic acid25,26. Ethanolic potassium 
hydroxide solution was added to collected piperine 
and refluxed for 90 min. The solution was evaporated 
to dryness under vacuum. It was cooled in an ice  
bath. Hot water was added to it, followed by 
hydrochloric acid. The resultant solution contains 
brown coloured piperidine and piperic acid. The 
precipitate formed was collected from the dark brown 
piperidine containing solution. It was washed with 
cold water, recrystallized from cold ethanol to get 
colourless piperic acid (20 mg) (Fig. 5b), which turns 
yellow on exposure to light27,28.  
Structural characterization of piperic acid 
The obtained product was analyzed by physico-
chemical studies and structural characterization by 
UV, IR, Mass, and NMR spectroscopy29,30. The UV 
absorbance of 0.01% w/v solution of the drug was 
determined between 200-400 nm. State: Yellow 
coloured compound. UV absorbance: 344 nm UV-
visible double beam spectrophotometer U-2900/U-
2910 (Lab India). IR997.37 (aromatic C-H str); 
2917.22 (O-H str); 2848.81 (C-H str); 1672.94 (C=O 
str); 1598.90 (C=C str); 1310.45 (C-O str); 1257.30 
(C-O str). MS (APCI-MS)(m/z; %):522 
(2M+H+;100), 217.0 (M+H+;35) (KBr disc method, 
Bruker optics-IFS 66v/s vacuum FT-IR). 1H NMR,(in 
ppm); 𝛿=7.75 (dd, J=15.2,11.8Hz, 1H,H-6); 𝛿=7.39 
(dd, J=9.1,1.3 Hz, 1H, H-7); 𝛿=7.10 (d, J=1.5 
Hz,1H,H-4); 𝛿=6.98 (dd, J=8.1,1.6Hz,1H, H-4’; 
𝛿=5.97(d, J=5.0 Hz, 2H, H 2); 𝛿=6.79 (m, 3H, H-1’,  
H-2’, H-3’).13CNMR (CDCl3) (in ppm); 𝛿= 140.24 
(C=O, C-5’); 𝛿= 140.24 (C-H, C-3’); 𝛿=137.22 (C-H,  
C-1’); 𝛿=125.78 (C-H, C-6); 𝛿=123.44 (C-H, C-2’); 
𝛿=122.92 (C-H, C-5); 𝛿=108.01 (C-H, C-4); 𝛿=105.52 
(C-H,C-7); 𝛿=101.32 (C-H,C-2). DEPT 13CNMR  
(in ppm); 𝛿=140.24; 137.22; 125.78; 123.44; 22.92; 
108.01; 105.52; 101.32 for C-5’, C-3’, C-1’, C-6, C-2‘,  
C-5, C-4, C-7 and C-2(Oxford 60 and 90 MHz NMR 
spectrometer, deuterated chloroform (CDCl3 ) as solvent. 
 
Acute toxicity testing 
The animals were overnight fasted prior to the 
experiment. Different doses (50–3000 mg/kg, orally) 
of the hydroalcoholic and acetone extracts of the plant 
and 2-piperidone were administered to groups of rats. 
The animals were observed continuously for 1 hour, 
next half-hourly intervals for 4 hours for any gross 
changes in their behaviour and then up to 24 hours for 
any mortality and toxicity as per the Organization for 
Economic Cooperation and Development (OECD) 
guidelines 42514,31, 32. 
 
Hepatoprotective activity by carbon tetrachloride-induced 
liver toxicity in rats 
Wistar rats (100-150 g), of either sex, 54 in number 
were equally divided into 9 groups containing 6 animals 
 
 
Fig. 5 — a) Structure of piperine and b) Hydrolysis of piperine to piperic acid 
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in each to assess the hepatoprotective potential of plant 
extracts and isolated phytoconstituents. The animals 
from Group I served as the control, received the 
vehicle (olive oil) p.o. at a dose of 1 mL/kg body 
weight. Group II served as the positive control, 
received the carbon tetrachloride in olive oil (1:1)  
2 mL/kg body weight orally once a day for 2 
successive days a week. Group III received standard 
drug silymarin at a dose of 17.5 mg/kg p.o. twice 
(9:00 a.m. and 4:00 p.m.) at 6 hours interval a day at 
the volume of 7.2 mL/kg. Silymarin was suspended in 
0.5% sodium carboxymethyl cellulose in distilled 
water. Test groups IV and V received G. serrata 
hydroalcoholic extract (GSHA) at a dose of 250 mg/kg 
at the volume of 7.2 mL/kg and 500 mg/kg at the 
volume of 7.5 mL/kg. Test groups VI and VII received 
acetone extract (GSAE) at a dose of 250 mg/kg at the 
volume of 7.5 mL/kg and 500 mg/kg at the volume of 
7.8 mL/kg. Test groups VIII and IX received isolated 
compound (GSC) at a dose of 0.25 mg/kg at the 
volume of 6.6 mL/kg and 0.5 mg/kg at the volume of 
7.5 mL/kg by gavage twice daily33,34. The stock 
solution of GSC was prepared in distilled water. The 
study duration was 28 days for all the treated groups. 
On termination, all animals were anaesthetized by 
injecting ketamine (100 mg/kg I.M.) in the thigh 
muscle35 and blood samples were collected separately 
by carotid bleeding into a sterilized dry centrifuge 
tube and allowed to coagulate at 37 oC for 30 minutes. 
The clear serum was separated and investigated for 
biochemical marker enzyme levels such as alanine 
aminotransferase (ALT/ SGPT) or serum glutamic 
pyruvic transaminase, aspartate aminotransferase 
(AST/ SGOT) or serum glutamic oxaloacetic 
transaminase and alkaline phosphatase (ALP) to 
assess the liver function (Table 3)32,36,37. 
Histopathology studies 
Livers were carefully collected, examined, rinsed 
with a solution of 10% NaCl, weighed and preserved 
in 10% formalin. Liver pieces (3-5) weighing about  
1 g were collected, fixed in formalin and carnoy 
solution. About 3-5 sections of each liver were 
embedded, cut, stained with azocarmine blue 
(AZAN), and observed under a trinocular microscope 
(Esaw) (Plate 1a-i)32,36-38. 
 
Statistical analysis 
The results were expressed as mean±SEM (Standard 
error mean) of 6 animals from each group. The data were 
evaluated by One-way ANOVA (Analysis of variance), 
followed by Dunnett’s multiple comparison tests. 
Differences among groups were significant at *P <0.05, 
**P <0.01, and ***P <0.001 respectively (Table 3). 
 
Results and Discussion 
The basified chloroform fractions (F1-F5) obtained 
by column chromatography were subjected to TLC to 
separate various types of alkaloids using appropriate 
solvent systems (Table 2). The TLC chromatograms 
developed reddish-brown spots after spraying with 
dragendorff’s reagent and brown spots after treatment 
with iodine vapour separately. The TLC profile of 
fractions (F1-F5) showed multiple spots. Further, the 
fractions (F1-F5) were subjected to column 
chromatography using the same solvent system (Table 
2) to get subfractions (Fa-Fe). The Fa, Fb, Fd and Fe 
showed multiple spots whereas Fc showed a single 
yellow spot in TLC studies (Table 2). All the 
subfractions were kept in the refrigerator for future 
study except Fc. The subfraction Fc was studied to 
detect the presence of pyridazine alkaloids as it showed 
a single prominent yellow spot. In TLC study the Rf 
value (0.63) obtained was comparable to the literature 
 
Table 3 — Hepatoprotective effects of G. serrata extracts and isolated compound by CCl4 induced hepatotoxicity method 
 
 
Treatments 
(Drug and dose) 
SGPT/ ALT 
(Mean) U/L 
SGOT/ AST 
(Mean) U/L 
ALP 
(Mean) U/L 
 Control/ Normal 127.7±0.57 102.1±0.40 199.25±1.20 
C
C
l 4 
in
du
ce
d 
CCl4 in olive oil (1:1), 2 mL/Kg 279.2±0.90 275.23±0.70 315.11±2.10 
Silymarin 17.5 mg/kg 131.0±0.80*** 106±0.60*** 207±0.50*** 
GSHA 250 mg/kg 181.2±6.68* 154.5±6.10*** 229.8±4.31** 
GSHA 500 mg/kg  147.5±2.77*** 144±4.38*** 208±0.77*** 
GSAE 250 mg/kg  192.2±4.68* 144.5±7.10*** 238.8±1.31*** 
GSAE 500 mg/kg  147.5±6.77*** 134±4.58*** 217.0±0.32*** 
GSC 0.25 mg/kg 160.0±0.59*** 127±1.24*** 236.0±1.03*** 
GSC 0.5 mg/kg 140.0±0.21*** 117±0.44*** 219.0±0.12*** 
Values are Mean±S.E.M. (n= 6 rats per each group). *P <0.05, **P <0.01, ***P <0.001 significantly different from the group treated 
with CC14, One-way ANOVA, Dunnett’s multiple comparison tests. 
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reports of one of the pyridine-piperidine alkaloids i.e., 
piperine39 Further, subfraction Fc was subjected to 
HPLC analysis to confirm the presence of piperine. 
In HPLC analysis the subfraction Fc showed 
similar retention time (Rt- 5.61 min) to that of 
standard piperine (Rt- 5.67 min) (Fig. 3,4). The 
subfraction Fc was injected into the HPLC system in 
the concentration of 1 mg/mL and the amount of 
piperine present was found to be 3.92% (Table 1). 
The separation was monitored at 343 nm. The isolated 
compound (70.1 mg) was yellow crystalline in nature 
with an ammonical smell, pepper-like taste with a 
melting point at 126 oC. It was slightly soluble in 
water, soluble in alcohol, chloroform, and ether. It 
showed UV absorbance at 343 nm. The obtained 
values correlated with literature data40. In the present 
study, piperine was isolated for the first time from this 
plant species (G. serrata). On treatment with 
 
 
Plate 1 — Effect of hydroalcoholic, acetone extracts of G. serrata and piperic acid on liver a) Histopathological Section of the liver tissue of
control/normal rat showing normal architecture of hepatocytes at portal triad, b) Histopathological section of the liver tissue of CCl4 treated 
rat showing severe necrosis (N), fibrosis (Arrow), vasculization (Dark arrow head), and fatty degeneration (Plane arrow head),
c) Histopathological section of the liver tissue of standard silymarin treated rat showing normal hepatocytes. CV indicates central vein and PT 
indicates portal triad32, d) Histopathological section of liver tissue of hydroalcoholic extract (GSHA 250 mg/kg) treated rat showing mild
degeneration and reverting to regeneration of hepatocytes, e) Histopathological section of liver tissue of hydroalcoholic extract (GSHA 500 
mg/kg) treated rat showing mild degeneration and reverting to regeneration of hepatocytes with moderate sized nucleus, central vein and 
portal, f) Histopathological section of liver tissue of acetone extract (GSAE 250 mg/kg) treated rat showing hepatocytes reverting to 
regeneration of hepatocytes with moderately sized nucleus, cenral vein and portal triad, g) Histopathological section of liver tissue of acetone 
extract (GSAE 500 mg/kg) treated rat showing almost regeneration of normal hepatocyte architecture with cenral vein and portal triad) 
Histopathological section of liver tissue of piperic acid (GSC 0.25mg/kg) treated rat showing normal architecture of hepatocytes with cenral 
vein and portal triad, h) Histopathological section of liver tissue of piperic acid (GSC 0.25mg/Kg) treated rat showing normal architecture of
hepatocytes with cenral vein and portal triad, and i) Histopathological section of liver tissue of piperic acid (GSC 0.5 mg/kg) treated rat 
showing complete regeneration and almost normal architecture of hepatocytes with normal sized nucleus and portal triad 
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alcoholic basic hydrolysis, the piperine was converted 
into piperic acid (Fig. 5b). The obtained piperic acid 
was subjected to structure elucidation studies. The 
hydrolysis into piperic acid further proves the 
presence of piperine in the selected species. 
The piperic acid obtained on hydrolysis was yellow 
in colour with a characteristic smell, m.p. 214 oC, 
insoluble in cold water and petroleum ether, soluble in 
boiling methanol, sparingly soluble in ether and 
benzene, which were comparable to literature data41. 
UV absorbance was found to be 344 nm. The IR 
spectrum showed a characteristic band at 2917.22 cm-1 
(O-H stretching) which indicates the presence of 
hydroxyl moiety. The other characteristic band at 
1672.94 cm-1 indicates the presence of carbonyl 
(C=O, stretching) group. The band at 1310.45 and 
1257.30 cm-1 correspond to (C-O stretching) (Fig. 6). 
The mass spectrum showed a molecular ion peak at 
m/z 217.0 which corresponds to the molecular weight 
and molecular formula (C12H10O4) of piperic acid 
(Fig. 7). In proton NMR spectrum (Fig. 8a-c) the 
compound showed a doublet of doublet at 𝛿= 7.75 ppm  
 
 
Fig. 6 — IR spectrum of piperic acid 
 
 
 
 
Fig. 7 — Mass spectrum of piperic acid 
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Fig. 8 — a) 1H NMR spectrum of piperic acid (0.5-7.5 ppm), b) 1H NMR spectrum of piperic acid expanded (0.0-6.5 ppm), and c) 1H 
NMR spectrum of piperic acid expanded (6.70-7.80 ppm) 
 
(dd, 1H, J = 15.2, 11.8) which is assignable to the 
aromatic proton of C-6. The spectrum exhibited 
another doublet of doublet at = 7.39 ppm (dd, 1H,  
J = 9.1, 1.3) indicating the single aromatic proton at 
C-7. Presence of doublet at 𝛿 = 7.10 ppm (d, 1H,  
J = 1.5) and doublet of doublet at 6.98 (dd, 1H,  
J = 8.1, 1.6) indicates single aromatic protons of C4 
and C4’, respectively. A doublet at 𝛿 = 5.97 ppm  
(d, 2H, J = 5.0) was assignable to two protons of C-2. 
A multiplet at 𝛿 = 6.79 indicates three protons of C-1’, 
C-2’, C-3’. The 13C NMR spectrum showed carbonyl 
carbon at 𝛿 = 140.24 ppm, at 𝛿 125.78, 123.44,  
122.92, 108.01. 105.52 and 101.32 ppm showed 
methylene carbons at C-6, C-2’, C-5, C-4, C-7, and  
C-2 (Fig. 9). DEPT 13CNMR spectrum showed 
methylene groups at 𝛿= 140.24, 137.22, 125.78, 
123.44, 122.92, 108.01, 105.52, 101.32 ppm for 
carbons at positions 5’, 3’, 1’, 6, 2‘, 5, 4, 7 and 2  
(Fig. 10).The compound passes dragendorff’s test for 
carboxyl functional groups. The results of spectroscopy 
agree with spectral data reported for piperic acid42, 
hence the obtained compound was confirmed to be 
piperic acid (Fig. 11). Acute toxicity studies revealed 
that both plant extracts and GSC (Piperic acid) did not 
produce any toxic symptoms when administered orally 
to rats at doses of 100-3000 mg/kg. The experiment 
recorded no toxic symptoms and no death of the 
animals during the study. 
The animal group administered with CCl4 in  
olive oil (1:1) showed significant increase in the 
levels of marker enzymes Plant extracts and standard 
drug silymarin demonstrated ability to counteract  
the CCl4 induced hepatotoxicity by decreasing the 
raised marker enzyme levels ALT, AST and ALP at  
P <0.05, P <0.01 and P <0.001 levels of significance 
compared to CCl4 induced positive control group. 
GSC treated group at 0.5 mg/kg showed a better 
reduction in the raised levels of marker enzymes ALT 
(140 U/L), and AST (117 U/L) compared to CCl4 
(ALT 279 and AST 275 U/L) induced positive control 
group. GSAE treated group at 500 mg/kg prominently 
reduced the raised levels of ALP (217 U/L) than GSC 
(ALP 219 U/L) at 0.5 mg/kg. GSAE treated group  
at 500 mg/Kg b/w (ALT 147, AST 144 and ALP 208 
U/L) and TPC treated group at 0.5 mg/kg b/w (ALT 
140, AST 117, and ALP 219 U/L) have exhibited 
better reduction in the raised levels of enzymes than 
other groups when compared to CCl4 induced positive  
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Fig. 9 — 13 CNMR spectrum of piperic acid 
 
 
 
Fig. 10 — DEPT 13 CNMR spectrum of piperic acid 
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control group at 17.5 mg/kg (ALT 279, AST 275, and 
ALP 315 U/L) (P <0.001) (Table 3). 
It was observed from the liver histopathological 
study that the normal control group had normal 
hepatic cell architecture with prominent sinusoidal 
spaces and a central vein32 (Plate 1a). The CCl4 
induced positive control group showed severe 
hepatocellular degeneration such as necrosis and fatty 
changes. Prominent damage to central lobular region 
appeared in the liver cells32 (Plate 1b). The 
histopathological studies of the liver section in the 
standard group have shown the normal cellular 
architecture, cytoplasm and visible central veins32 
(Plate 1c). GSHA treated group at 250 mg/kg and  
500 mg/kg has shown moderate recovery and 
protection of hepatocytes degradation (Plate 1d,e). 
GSAE treated group at 250 mg/kg has shown 
moderate recovery (Plate 1f), but at the dose of  
500 mg/kg offered normal hepatocytes recovery and 
protection of hepatocytes degradation (Plate 1g). GSC 
treated group at 0.25 and 0.5 mg/kg restored the 
structural damages (Plate 1h,i) induced by CCl4. 
Treatment with GSHA, GSAE, and GSC decreased 
the abnormal liver architecture induced by CCl4 (Plate 
1d-i) and restored the altered histopathological 
changes. GSAE treated group at 500 mg/kg (Plate 1g) 
and GSC treated group at 0.5 mg/kg (Plate 1i) 
exhibited better regeneration of hepatocytes when 
compared to normal control. GSC treated group 
showed better recovery of hepatocytes than plant 
extracts compared to control. The results indicate that 
plant extracts exhibited hepatoprotective activity due 
to piperic acid obtained by hydrolysis of piperine. 
Piperic acid was studied for the first time for 
hepatoprotective activity. Therefore both plant 
extracts and piperic acid can treat hepatic ailments. 
CCl4 induced hepatotoxicity causes peroxidative 
degradation in the adipose tissue resulting in fatty 
infiltration of the hepatocytes. Further, it causes liver 
steatosis, a process involving endoplasmic reticulum 
(ER) stress-induced cytochrome P450 2E1 activation 
and ROS (Reactive Oxygen Species) production43. 
Cytochrome P450 2E1 is a key enzyme in the 
metabolic activation of many low molecular weight 
toxicants, an important contributor to oxidative stress 
found predominantly in the ER of the liver. The 
changes associated with CCl4 are biotransformed by 
the cytochrome P-450 system to produce CCl3 a free 
radical, that binds to lipoprotein, leads to peroxidation 
of lipids of ER and finally result in cell death44,45. 
Cytosol releases a variety of enzymes into the 
bloodstream during liver cell plasma membrane 
damage. The increased levels of ALT, AST and ALP 
show cellular leakage and loss of functional integrity 
of the cell membrane as a result of hepatic 
damage46,47. Their estimation in the serum is a useful 
measure for determining the hepatocellular damage46. 
All the treated animals showed significantly increased 
levels of the liver markers. The treatment with plant 
extracts and GSC decreased the raised levels of 
biochemical marker enzymes (Table 3). 
A comparative histological examination of liver 
from the study groups further corroborated the 
hepatoprotective effect of G. serrata extracts and 
piperic acid. Histological profile from the normal 
control group showed prominent central vein and 
normal arrangement of hepatic cells (Plate 1a). 
Histopathological examination of CCl4 induced liver 
section showed higher degrees of pathological 
changes centrilobular necrosis of hepatic cells, 
vacuolization and fatty regeneration (Plate 1b). The 
animals treated with plant extracts (GSHA 250 and 
500 mg/kg) (Plate 1d,e) showed moderate recovery 
where GSAE at 500 mg/kg (Plate 1g) and piperic acid 
(GSC) at 0.5 mg/kg (Plate 1i) showed more prominent 
recovery of hepatic cell damage. It was clear that 
necrosis was absent, normal hepatic cords and lesser 
fatty infiltration were present. The observations show 
that acetone extract exhibited hepatoprotective 
response due to piperidine moiety. HPLC analysis 
indicated piperine from chloroform fraction of 
acetone extract (Table 1; Fig. 3,4). The compound 
piperic acid obtained on the degradation of piperine 
demonstrated more effective functional improvement of 
hepatocytes than plant extracts. The results of the 
histopathological study also support the results of 
biochemical trials.  
G. serrata exhibited antidiabetic and antioxidant 
activity on streptozotocin-induced diabetic rats where 
the plant extracts inhibited ROS formation induced  
by streptozotocin48. Phytochemicals isolated from  
G. serrata, kaempferol49 and oleuropein50 have 
exhibited hepatoprotective activity. Comparative 
results show that piperic acid exhibited better activity 
than kaempferol and oleuropein. Further, the 
 
 
Fig. 11 — Piperic acid 
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hepatoprotective studies conducted on plant extracts 
and piperic acid were comparable to the earlier 
literature reports51,52. Moreover, piperic acid inhibits 
lipoxygenase (LOX) activity53. Piperic acid prevents 
experimentally induced ER stress in vitro54. The 
antihyperlipidemic activity was reported with respect  
to simvastatin55, a specific inhibitor of 3-hydroxy-3-
methylglutaryl-coenzyme A (HMG-CoA) reductase, 
which regulates cholesterol biosynthesis, mainly in the 
liver56. It also exhibited potent anti-inflammatory57, and 
free radical scavenging properties58. Therefore, from 
the current research findings and in correlation to the 
available literature reports the possible mechanism of 
action of G. serrata acetone extracts and piperic acid 
may be by inhibiting ER stress-induced cytochrome  
P 450 2E1 activation and ROS production. The present 
study reveals that the hepatoprotective activity of floral 
extracts might be due to in situ conversion of piperine 
into piperic acid. Since synthetic derivatives produce 
harmful effects, G. serrata floral acetone extracts and 
simple molecule such as piperic acid can be used to 
treat hepatic disorders as they controlled the liver 
enzymes elevation which was supported through 
histological findings. 
 
Conclusion 
In conclusion, the results of the study indicate that 
the compound piperic acid obtained by hydrolysis of 
piperine showed a significant decrease in the raised 
enzyme levels as well as regeneration of hepatocytes 
equipotent to standard drug silymarin against CCl4 
induced hepatotoxicity. Further studies can be carried 
out to develop piperic acid as a potential 
hepatoprotective agent. 
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